Alec Kacew

A phase II study of nivolumab (N) plus ipilimumab (I) in radioidine refractory differentiated thyroid cancer (RAIR DTC) with exploratory cohorts in anaplastic (ATC) and medullary thyroid cancer (MTC).

Jochen H. Lorch, Justine A. Barletta, Matthew A. Nehs et al. · Journal of Clinical Oncology · 2020 · 62 citations

Aggressive Tc, Pharmacotherapy, Immunotherapy +18

COVIDOSE: A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia

Garth W. Strohbehn, Brian L. Heiss, Sherin J. Rouhani et al. · Clinical Pharmacology & Therapeutics · 2020 · 58 citations · Full text

Inflammation, Clinical Immunology, Noncritical Covid‐19 Pneumonia +15

Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping

Alec Kacew, Garth W. Strohbehn, Loren Saulsberry et al. · Frontiers in Oncology · 2021 · 55 citations · Full text

Artificial Intelligence, Oncology, Health Informatics +14

Oral keratosis of unknown significance shares genomic overlap with oral dysplasia

Alessandro Villa, Glenn J. Hanna, Alec Kacew et al. · Oral Diseases · 2019 · 53 citations

Everolimus in Anaplastic Thyroid Cancer: A Case Series

Ethan Harris, Glenn J. Hanna, Nicole G. Chau et al. · Frontiers in Oncology · 2019 · 41 citations · Full text